| |
|
|
|
Antares Pharma- Inc.  
|
|
2.83 -0.04 (-0.01%) |
06-20 15:08 |
|
Open: |
2.9 |
Pre close: |
2.87 |
Target:
|
3.48
|
|
High: |
2.93 |
Low: |
2.78 |
Resistance:
|
2.98
3.48
|
|
Volume: |
788,174 |
Market Cap: |
444M |
Support:
|
2.62
2.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.87
 |
MACD |
MACD(12,26):
|
0.11 |
|
MA(20): |
2.71  |
Signal(12,26,9): |
0.10 |
|
MA(100): |
2.38 |
Stochastic Oscillator |
%K(14,3):
|
72.49 |
|
MA(250): |
2.52 |
%D(3): |
78.51 |
|
Average Volume(K) |
3-Month: |
90720
|
52-Week |
High:
|
4.09 |
|
10-Days: |
92886 |
Low: |
1.58 |
|
RSI |
RSI(14):
|
60.90 |
Change(%): |
-6.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.110 |
Return on Equity (ttm) |
-47.8 |
Shares Out. (M) |
156.83 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-25.4 |
Shares Float (M) |
139.03 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.49 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-1.1 |
% Held by Institutions |
31.50 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.091 |
Shares Short (K) |
6191 |
|
Book Value (p.s.) |
16.160 |
EBITDA (p.s.) |
-0.042 |
P/E |
-25.64 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.17 |
|
Profit Margin |
-32.22 |
Operating Cash Flow
(M) |
-23.09 |
P/S |
1263601664.00 |
|
Operating Margin |
-30.18 |
Levered Free Cash Flow
(M) |
-17.42 |
P/CF |
-19.15 |
|
|
|
|
|
|
